Nutrient-stimulated Hormone-based Therapies: A New Frontier in the Prevention and Management of MASH-associated Hepatocellular Carcinoma. [PDF]
Phillips R +4 more
europepmc +1 more source
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies. [PDF]
Trapanese V +10 more
europepmc +1 more source
Cinnamon-Derived Phytonutrients as Modulators of Ion Channels and G Protein-Coupled Receptor Signaling in Metabolic Diseases. [PDF]
Tjandrawinata RR +4 more
europepmc +1 more source
Pathogenesis of type 2 diabetes in Japan and East Asian populations: Basic and clinical explorations. [PDF]
Seino Y, Yamazaki Y.
europepmc +1 more source
Can we slow down the decline in renal function? [PDF]
Cice G, Calò L.
europepmc +1 more source
Crosstalk Within the Intestinal Epithelium: Aspects of Intestinal Absorption, Homeostasis, and Immunity. [PDF]
Yu LE, Yang WC, Liang YC.
europepmc +1 more source
The Gut Microbiome's Influence on Incretins and Impact on Blood Glucose Control. [PDF]
Dulai AS, Min M, Sivamani RK.
europepmc +1 more source
Incretin system and glucagon secretion in patients with chronic pancreatitis. [PDF]
Ciccarelli G +16 more
europepmc +1 more source
The Roles of Incretin Hormones GIP and GLP-1 in Metabolic and Cardiovascular Health: A Comprehensive Review. [PDF]
Yamanouchi D.
europepmc +1 more source
Related searches:
Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are the known incretin hormones in humans, released predominantly from the enteroendocrine K and L cells within the gut. Their secretion is regulated by a complex of integrated mechanisms involving direct contact for the activation of different chemo-sensors on the ...
A. Deane, M. Horowitz
semanticscholar +5 more sources

